SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 58.53 |
Enterprise Value ($M) | n/a |
Book Value ($M) | -26.92 |
Book Value / Share | -0.21 |
Price / Book | n/a |
NCAV ($M) | -32.33 |
NCAV / Share | -0.25 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -0.93 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.24 |
Current Ratio | 0.24 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.34 |
Assets | 10.76 |
Liabilities | 37.68 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 2.62 |
Operating Income | -15.81 |
Net Income | -14.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -12.94 |
Cash from Investing | 0.02 |
Cash from Financing | 13.54 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
GPLB – Green Planet Bioengineering Co., Ltd. | GRTX – Galera Therapeutics, Inc. |
GSAC – GelStat Corp. | GSTC – GlobeStar Therapeutics Corporation |
HENC – Hero Technologies Inc. |
Financial data and stock pages provided by
Fintel.io